欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Ind
ISSN号:1543-8384
期刊名称:Molecular Pharmaceutics
时间:2012.4.4
页码:48994-
相关项目:克服ABC药物转运泵介导肿瘤细胞多药抗药性的新策略
作者:
Xie JD|Liang YJ|Liang YJ|Zhao XQ|Zhao XQ|Chen WQ|Chen WQ|Fu LW|Fu LW|
同期刊论文项目
克服ABC药物转运泵介导肿瘤细胞多药抗药性的新策略
期刊论文 12
同项目期刊论文
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance..
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-B
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of
Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population
Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vi
Axitinib Targeted Cancer Stem like Cells to Enhance Efficacy of Chemotherapeutic Drugs via Inhibitin